BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 20562849)

  • 1. CD90/THY1 is overexpressed in prostate cancer-associated fibroblasts and could serve as a cancer biomarker.
    True LD; Zhang H; Ye M; Huang CY; Nelson PS; von Haller PD; Tjoelker LW; Kim JS; Qian WJ; Smith RD; Ellis WJ; Liebeskind ES; Liu AY
    Mod Pathol; 2010 Oct; 23(10):1346-56. PubMed ID: 20562849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-promoting phenotype of CD90hi prostate cancer-associated fibroblasts.
    Zhao H; Peehl DM
    Prostate; 2009 Jun; 69(9):991-1000. PubMed ID: 19267366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dicarbonyl/L-xylulose reductase: a potential biomarker identified by laser-capture microdissection-micro serial analysis of gene expression of human prostate adenocarcinoma.
    Cho-Vega JH; Tsavachidis S; Do KA; Nakagawa J; Medeiros LJ; McDonnell TJ
    Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2615-22. PubMed ID: 18086765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Asporin is a stromally expressed marker associated with prostate cancer progression.
    Rochette A; Boufaied N; Scarlata E; Hamel L; Brimo F; Whitaker HC; Ramos-Montoya A; Neal DE; Dragomir A; Aprikian A; Chevalier S; Thomson AA
    Br J Cancer; 2017 Mar; 116(6):775-784. PubMed ID: 28152543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of gene expression in prostate cancer epithelial and interstitial stromal cells using laser capture microdissection.
    Gregg JL; Brown KE; Mintz EM; Piontkivska H; Fraizer GC
    BMC Cancer; 2010 Apr; 10():165. PubMed ID: 20426842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Golgi protein GOLM1 is a tissue and urine biomarker of prostate cancer.
    Varambally S; Laxman B; Mehra R; Cao Q; Dhanasekaran SM; Tomlins SA; Granger J; Vellaichamy A; Sreekumar A; Yu J; Gu W; Shen R; Ghosh D; Wright LM; Kladney RD; Kuefer R; Rubin MA; Fimmel CJ; Chinnaiyan AM
    Neoplasia; 2008 Nov; 10(11):1285-94. PubMed ID: 18953438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of Thy1 (CD90) expression in neuroblastomas is correlated with impaired survival.
    Fiegel HC; Kaifi JT; Quaas A; Varol E; Krickhahn A; Metzger R; Sauter G; Till H; Izbicki JR; Erttmann R; Kluth D
    Pediatr Surg Int; 2008 Jan; 24(1):101-5. PubMed ID: 17952444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expression of CD90/Thy-1 in hepatocellular carcinoma: an in vivo and in vitro study.
    Sukowati CH; Anfuso B; Torre G; Francalanci P; Crocè LS; Tiribelli C
    PLoS One; 2013; 8(10):e76830. PubMed ID: 24116172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of CD90 (Thy-1) in pancreatic adenocarcinoma present in the tumor microenvironment.
    Zhu J; Thakolwiboon S; Liu X; Zhang M; Lubman DM
    PLoS One; 2014; 9(12):e115507. PubMed ID: 25536077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate-specific antigen mRNA and protein levels in laser microdissected cells of human prostate measured by real-time reverse transcriptase-quantitative polymerase chain reaction and immuno-quantitative polymerase chain reaction.
    Pinzani P; Lind K; Malentacchi F; Nesi G; Salvianti F; Villari D; Kubista M; Pazzagli M; Orlando C
    Hum Pathol; 2008 Oct; 39(10):1474-82. PubMed ID: 18619642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene-expression analysis of gleason grade 3 tumor glands embedded in low- and high-risk prostate cancer.
    Hoogland AM; Böttcher R; Verhoef E; Jenster G; van Leenders GJ
    Oncotarget; 2016 Jun; 7(25):37846-37856. PubMed ID: 27191985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 Immunostaining guided laser capture microdissection (p53-LCM) defines the presence of p53 gene mutations in focal regions of primary prostate cancer positive for p53 protein.
    Griewe GL; Dean RC; Zhang W; Young D; Sesterhenn IA; Shanmugam N; McLeod DG; Moul JW; Srivastava S
    Prostate Cancer Prostatic Dis; 2003; 6(4):281-5. PubMed ID: 14663467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene promoter methylation in prostate tumor-associated stromal cells.
    Hanson JA; Gillespie JW; Grover A; Tangrea MA; Chuaqui RF; Emmert-Buck MR; Tangrea JA; Libutti SK; Linehan WM; Woodson KG
    J Natl Cancer Inst; 2006 Feb; 98(4):255-61. PubMed ID: 16478744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stromal insulin-like growth factor binding protein 3 (IGFBP3) is elevated in the diseased human prostate and promotes ex vivo fibroblast-to-myofibroblast differentiation.
    Sampson N; Zenzmaier C; Heitz M; Hermann M; Plas E; Schäfer G; Klocker H; Berger P
    Endocrinology; 2013 Aug; 154(8):2586-99. PubMed ID: 23720424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selenium and vitamin E: cell type- and intervention-specific tissue effects in prostate cancer.
    Tsavachidou D; McDonnell TJ; Wen S; Wang X; Vakar-Lopez F; Pisters LL; Pettaway CA; Wood CG; Do KA; Thall PF; Stephens C; Efstathiou E; Taylor R; Menter DG; Troncoso P; Lippman SM; Logothetis CJ; Kim J
    J Natl Cancer Inst; 2009 Mar; 101(5):306-20. PubMed ID: 19244175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression down-regulation in CD90+ prostate tumor-associated stromal cells involves potential organ-specific genes.
    Pascal LE; Goo YA; Vêncio RZ; Page LS; Chambers AA; Liebeskind ES; Takayama TK; True LD; Liu AY
    BMC Cancer; 2009 Sep; 9():317. PubMed ID: 19737398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The anterior gradient 2 (AGR2) gene is overexpressed in prostate cancer and may be useful as a urine sediment marker for prostate cancer detection.
    Bu H; Bormann S; Schäfer G; Horninger W; Massoner P; Neeb A; Lakshmanan VK; Maddalo D; Nestl A; Sültmann H; Cato AC; Klocker H
    Prostate; 2011 May; 71(6):575-87. PubMed ID: 20945500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Truncated Bcl-2, a potential pre-metastatic marker in prostate cancer.
    Huang JM; Lin TY; Chang D; Lin SL; Ying SY
    Biochem Biophys Res Commun; 2003 Jul; 306(4):912-7. PubMed ID: 12821128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD90(+) stromal cells are the major source of IL-6, which supports cancer stem-like cells and inflammation in colorectal cancer.
    Huynh PT; Beswick EJ; Coronado YA; Johnson P; O'Connell MR; Watts T; Singh P; Qiu S; Morris K; Powell DW; Pinchuk IV
    Int J Cancer; 2016 Apr; 138(8):1971-81. PubMed ID: 26595254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thy1 (CD90) Expression Is Elevated in Radiation-Induced Periprosthetic Capsular Contracture: Implication for Novel Therapeutics.
    Hansen TC; Woeller CF; Lacy SH; Koltz PF; Langstein HN; Phipps RP
    Plast Reconstr Surg; 2017 Aug; 140(2):316-326. PubMed ID: 28746279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.